Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
Clinical trial NCT03969420 · TERMINATED
Trial details
- NCT number
- NCT03969420
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2021-04-22
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.